Content Conference Coverage Conferences CROI 2014
CROI 2014: Raltegravir Has Edge Over 2 HIV Protease inhibitors in 3-Drug Comparison
- Details
- Category: HIV Treatment
- Created on Friday, 14 March 2014 00:00
In a head-to-head comparison of 3 drugs presented at the 21st Conference on Retroviruses and Opportunistic Infections (CROI) last week in Boston, the integrase inhibitor raltegravir (Isentress) proved to be superior, in terms of the overall likelihood of treatment failure, when compared to 2 ritonavir-boosted protease inhibitors, atazanavir (Reyataz) and darunavir (Prezista).
CROI 2014: Raltegravir Plus Boosted Darunavir Is Safe and Effective for First-line ART
- Details
- Category: HIV Treatment
- Created on Thursday, 06 March 2014 00:00
A NRTI-sparing initial regimen of raltegravir (Isentress) plus boosted darunavir (Prezista) worked as well as traditional antiretroviral therapy containing tenofovir/emtricitabine (the drugs in Truvada), according to findings from the NEAT 001 study reported at the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) this week in Boston.
CROI 2014: The Role of Interferon in HIV Response [VIDEO]
- Details
- Category: HIV Treatment
- Created on Monday, 03 March 2014 00:00
Although interferon is on its way out as a standard of care for hepatitis C, researchers are learning more about its role in HIV, conference vice chair Julie Overbaugh said at a media briefing on the opening day of the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) this week in Boston.
CROI 2014: Retrovirus Conference Now Underway in Boston
- Details
- Category: HIV Treatment
- Created on Monday, 03 March 2014 00:00
The 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) kicked off in Boston this week with a program for young investigators, a press conference on new hepatitis C treatments, and opening lectures on HIV immune response and cross-species transmission and an update on the epidemic in West Africa.
HIVandHepatitis.com will be on site all week bringing you the latest news.
CROI 2014: Retrovirus Conference Starts Monday in Boston
- Details
- Category: HIV Treatment
- Created on Friday, 28 February 2014 00:00
The 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) will take place next week, March 3-6, at the Hynes Convention Center in Boston. HIVandHepatitis.com will be on site all week to bring you the latest news coverage about HIV, hepatitis C, and related topics.
More Articles...
- CROI 2014: New NNRTI Doravirine Matches Efavirenz for First-line HIV Treatment
- CROI 2014: Novel 2-Drug Maintenance Combo Works Well, Stage Set for Long-lasting Injectables
- CROI 2014: Long-Acting HIV Drugs for Maintenance Therapy [VIDEO]
- CROI 2014: Raltegravir Works as Well as Tenofovir for HIV Treatment [VIDEO]
- CROI 2014: HIV Attachment Inhibitor BMS-663068 Shows Good Safety and Efficacy in Phase 2b
- CROI 2014: Early Treatment Reduces Viral Reservoirs but Does Not Prevent Rebound
- CROI 2014: Early Antiretroviral Therapy May Limit Gut Damage and Immune Activation
- CROI 2014: Boston Patients Experience HIV Rebound after Stem Cell Transplants
- CROI 2014: HIV Rebounds in Boston Bone Marrow Transplant Patients [VIDEO]
- CROI 2014: Protected T-cells Persist and Proliferate in HIV Gene Therapy Study
- CROI 2014: HIV Cure News from the Retrovirus Conference
- CROI 2014: Mississippi Child Remains Free of HIV [VIDEO]
- CROI 2014: HIV Cure May Need Multiple Components, Workshop Delegates Hear
- CROI 2014: Disparities in Viral Suppression in Washington, DC [VIDEO]
- CROI 2014: Women with Circumcised Partners Less Likely to Have HIV
- CROI 2014: Depo-Provera Contraceptive Linked to HIV Acquisition [VIDEO]
- CROI 2014: Very Different Levels of PrEP Uptake and Adherence in 3 U.S. Cities
- CROI 2014: Dapivirine Vaginal Ring Appears Safe and Effective in Tissue Study
- CROI 2014: Nipping HIV in the Bud -- Could We Use Genotyping to Interrupt Transmission?
- CROI 2014: HIV Incidence at Record High Among Young Gay Black Men in Southern U.S.
- CROI 2014: Monkey Studies Confirm Validity of Injectable PrEP
- CROI 2014: Long-acting GSK744 Protects Monkeys against HIV-like Virus [VIDEO]
- CROI 2014: HIV in People Who Use Drugs [VIDEO]
- CROI 2014: HIV Transmission through Condomless Sex [VIDEO]
- CROI 2014: HIV Treatment as Prevention Works in PARTNER Study
- CROI 2014: Treatment as Prevention Dramatically Lowers HIV Sexual Transmission [VIDEO]
- CROI 2014: No One with Undetectable Viral Load Transmits HIV in PARTNER Study
- CROI 2014: Tenofovir Alone May Work as Well as Truvada for Pre-exposure Prophylaxis
- CROI 2014: Self-Reports Did Not Reflect Actual Gel or Pill Use in VOICE PrEP Trial
- CROI 2014: Cumulative Viral Load and HIV Disease Progression
- CROI 2014: Chronic Lung Disease Is Prevalent and Under-diagnosed in People with HIV
- CROI 2014: Researchers Discuss HIV, Aging, and Frailty
- CROI 2014: Heart Attack Link to Abacavir Persists in D:A:D Study
- CROI 2014: Heart Attack Risk May Be Falling for People with HIV -- But Not for Women
- CROI 2014: Depression and HIV are Risk Factors for Heart Failure Among Veterans
- CROI 2014: Tesamorelin Growth-Hormone Releaser Reduces Liver Fat in People with HIV
- CROI 2014: Vitamin D and Rosuvastatin Improve Bone Loss in People with HIV
- CROI 2014: Newborns Exposed to Tenofovir Have Lower Bone Content [VIDEO]
- CROI 2014: Neurocognitive Problems, Depression, and Early ART in People with HIV
- CROI 2014: People with HIV More Likely to Die of Many Common Cancers
- CROI 2014: STIs Increase Risk of HIV Infection During Pregnancy
- CROI 2014: Efavirenz Matches Lopinavir/ritonavir for Perinatal HIV Treatment
- CROI 2014: Lopinavir or Lamivudine Equally Protective Against HIV During Breast-feeding
- CROI 2014: Maternal Deaths Due to HIV Not Declining Despite PMTCT Successes In South Africa
- CROI 2014: Men Not Benefiting as Much as Women from HIV Treatment in Africa [VIDEO]
- Hepatitis C Cascade Studies Show Gaps in Testing and Treatment
- CROI 2014 & EASL 2014: Treating Hepatitis B and C in HIV+ People Reduces Liver Disease
- CROI 2014: Hepatitis C Treatment in the Real World [VIDEO]
- Advances in Hepatitis C Treatment: the Future Is Now [VIDEO]
- CROI 2014: Interferon-free BMS Combo Cures 90% of Genotype 1 Hepatitis C
- CROI 2014/APASL 2014: Merck Combo Suppresses HCV in Monoinfected and Coinfected Patients
- CROI 2014: Daclatasvir + Simeprevir Effective Against Hepatitis C Genotype 1b
- CROI 2014: Simeprevir Cures Almost 80% of First-time HIV/HCV Coinfected Patients
- CROI 2014: AbbVie 3D Combination Cures 99% of Genotype 1b Hepatitis C
- CROI 2014: Short 6-Week Oral Treatment Works for Most Hepatitis C Patients
- CROI 2014: Faldaprevir + Interferon Cures HIV/HCV Coinfected People
- CROI 2014: Sofosbuvir + Ribavirin Cures 75% of Genotype 1 HIV/HCV Coinfected Patients
- Studies Shed Light on Hepatitis C Virus Sexual Transmission among Gay Men
- CROI 2014: How Fast Does Fibrosis Progress in Acute Hepatitis C Patients with and without HIV?
- CROI 2014: New Drugs, Novel Combos Top Tuberculosis News at Conference
- CROI 2014: Natural History of HIV-Related Anal Dysplasia [VIDEO]
Web Design and Development by